Regulation of drug-metabolizing enzymes by sex-related hormones: clinical implications for transgender medicine
- 26 April 2022
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 43 (7) , 582-592
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7International Journal of Transgenderism, 2012
- Expression and activities of hepatic cytochrome P450 (CYP1A, CYP2A and CYP2E1) in entire and castrated male pigsAnimal, 2012
- Sex Differences in Drug DispositionBioMed Research International, 2011
- Body Composition and Bone Mineral Density in Male-to-Female Transsexuals During Cross-Sex Hormone Therapy Using Gonadotrophin-Releasing Hormone AgonistExperimental and Clinical Endocrinology & Diabetes, 2010
- Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymesExpert Opinion on Drug Metabolism & Toxicology, 2010
- Sex Differences in the Expression of Hepatic Drug Metabolizing EnzymesMolecular Pharmacology, 2009
- Sex Differences in Pharmacokinetics and PharmacodynamicsClinical Pharmacokinetics, 2009
- Dehydroepiandrosterone Induces Human CYP2B6 through the Constitutive Androstane ReceptorDrug Metabolism and Disposition, 2007
- The Biological Actions of Dehydroepiandrosterone Involves Multiple ReceptorsDrug Metabolism Reviews, 2006
- Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in menBritish Journal of Clinical Pharmacology, 2003